Galician consensus on management of cardiotoxicity in breast cancer: risk factors, prevention, and early intervention.
This Galician consensus statement is a joint oncologists/cardiologists initiative indented to establish basic recommendations on how to prevent and to manage the cardiotoxicity in breast cancer with the aim of ensuring an optimal cardiovascular care of these patients. A clinical screening of the patients before treatment is recommended to stratify them into a determined risk group based on their intrinsic cardiovascular risk factors and those extrinsic arose from breast cancer therapy, thereby providing individualized preventive and monitoring measures. Suitable initial and ongoing assessments for patients with low and moderate/high risk and planned treatment with anthracyclines and trastuzumab are given; also, measures aimed at preventing and correcting any modifiable risk factor are pointed out .
Oncology Department, Complejo Hospitalario Universitario Santiago de Compostela, Santiago de Compostela, Spain. jfcueva@gmail.com.
J F
JF
Cueva
Oncology Department, Complejo Hospitalario Universitario A Coruña, A Coruña, Spain.
S
S
Antolín
Oncology Department, Complejo Hospitalario Universitario A Coruña, A Coruña, Spain.
L
L
Calvo
Oncology Department, Complejo Hospitalario Universitario Vigo, Vigo, Spain.
I
I
Fernández
Oncology Department, Centro Oncológico Galicia, A Coruña, Spain.
M
M
Ramos
Oncology Department, Complejo Hospitalario Universitario Ferrol, Ferrol, Spain.
L
L
de Paz
Oncology Department, Complejo Hospitalario Universitario Ourense, Orense, Spain.
J G
JG
Mata
Oncology Department, Complejo Hospitalario Universitario Santiago de Compostela, Santiago de Compostela, Spain.
R
R
López
Oncology Department, Complejo Hospitalario Universitario Pontevedra, Pontevedra, Spain.
M
M
Constenla
Oncology Department, Complejo Hospitalario Universitario Ourense, Orense, Spain.
E
E
Pérez
Oncology Department, Centro Oncológico Galicia, A Coruña, Spain.
A
A
González
Oncology Department, Complejo Hospitalario Universitario Ferrol, Ferrol, Spain.
M L
ML
Pellón
Oncology Department, Complejo Hospitalario Universitario Lugo, Lugo, Spain.
S
S
Varela
Cardiology Department, Hospital Universitario La Paz, Madrid, Spain.
T
T
López
D000970:Antineoplastic Agents / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000188:drug therapy*; D066126:Cardiotoxicity / Q000209:etiology / Q000517:prevention & control*; D005260:Female; D006801:Humans; D012307:Risk Factors
D000970:Antineoplastic Agents
Anticancer therapies; Breast cancer; Cardiotoxicity; Cardiovascular risk factors